We are live on ! Find out more
PVMCV

Polaris Venture Management Co V Portfolio holdings

AUM $14.1M
1-Year Est. Return 121.41%
This Fund
S&P 500
This Quarter Est. Return
+89.21%
1 Year Est. Return
+121.41%
3 Year Est. Return
+281.18%
5 Year Est. Return
+1,023.01%
10 Year Est. Return
–
AUM
$76.6M
AUM Growth
+$16M
Cap. Flow
-$21.3M
Cap. Flow %
-27.74%
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
FATE icon
Fate Therapeutics
FATE
+$17.7M
2
STIM icon
Neuronetics
STIM
+$3.56M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FATE icon
1
Fate Therapeutics
FATE
$307M
$51.8M 67.63%
569,889
-284,947
-33% -$17.7M
LYRA
2
DELISTED
LYRA THERAPEUTICS INC
LYRA
$12.6M 16.38%
22,017
– –
RNAC icon
3
Cartesian Therapeutics
RNAC
$243M
$8.4M 10.97%
92,449
– –
XFOR icon
4
X4 Pharmaceuticals
XFOR
$407M
$2M 2.61%
10,383
– –
ATYR
5
aTyr Pharma
ATYR
$51.6M
$507K 0.66%
130,572
– –
GNCA
6
DELISTED
Genocea Biosciences, Inc.
GNCA
$478K 0.62%
197,345
– –
DARE icon
7
Dare Bioscience
DARE
$20.5M
$437K 0.57%
27,187
– –
PULM icon
8
Pulmatrix
PULM
$6.17M
$428K 0.56%
17,972
– –
STIM icon
9
Neuronetics
STIM
$159M
– –
-732,583
Closed -$3.56M

Similar funds

IFC
Intact Financial Corporation Toronto, Ontario, Canada $14M AUM
AG
Ashmore Group London, United Kingdom $16.3M AUM 57.83% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
IR
Invictus RG Hamilton, Bermuda $8.9M AUM 56.32% 1-Year Est. Return
CCM
Copernicus Capital Management San Francisco, California $8.26M AUM 37.91% 1-Year Est. Return
EIP
Edgbaston Investment Partners $20.3M AUM 35.98% 1-Year Est. Return
AAM
Areion Asset Management Hong Kong $7.82M AUM 16% 1-Year Est. Return
OEP
Ocean Endowment Partners Chicago, Illinois $20.6M AUM 27.63% 1-Year Est. Return

Polaris Venture Management Co V's Q4 2020 Portfolio in Review

As of Q4 2020, Polaris Venture Management Co V held 9 positions worth $76.6M, up 26% from $60.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Polaris Venture Management Co V withdrew a net $21.3M in Q4 2020, closing 1 position and reducing 1 holding. Its most notable exit was Neuronetics, an estimated $3.56M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Polaris Venture Management Co V's biggest Q4 2020 reduction was Fate Therapeutics, cutting an estimated $17.7M.
  • Polaris Venture Management Co V fully exited Neuronetics in Q4 2020, selling an estimated $3.56M.
  • Polaris Venture Management Co V's ten largest holdings make up 100% of its $76.6M portfolio in Q4 2020.
  • Polaris Venture Management Co V opened 0 new positions and closed 1 in Q4 2020.
  • Polaris Venture Management Co V's portfolio value rose 26% quarter-over-quarter to $76.6M.

Based on Polaris Venture Management Co V's 13F filing for Q4 2020, filed 12 Feb 2021.